Skip to content
For laboratory research use only · Not for human or veterinary use · Qualified buyers only
Learn

Peptides and Compounds in Hair-Follicle Research: Models and Published Findings

A research-use overview of GHK-Cu, RU58841, and mitochondrial-metabolism compounds in hair-follicle models, with attributed published findings and documentation notes.

Peptides and Compounds in Hair-Follicle Research: Models and Published Findings

Hair-follicle research uses more than one chemical class. The original overview of this page groups three recurring laboratory themes: PP405 and mitochondrial-metabolism models, RU58841 and androgen-receptor research, and GHK-Cu and extracellular-matrix questions. Those themes are not interchangeable protocols, and a catalog name is not a completed experimental design.

Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about Velnacor catalog material and are not instructions for use in people or animals.

GHK-Cu and extracellular-matrix questions

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. In fibroblast-culture experiments, Maquart and colleagues reported that GHK-Cu stimulated collagen synthesis in vitro (Maquart et al., 1988). That result is a cell-culture extracellular-matrix finding. It does not, by itself, establish an outcome in a hair-follicle assay or in a clinical setting.

A later review by Pickart and Margolina summarized a broader set of reported observations for GHK-Cu, including effects on extracellular-matrix proteins and a statement that laboratory work has reported increased hair-follicle size (Pickart and Margolina, 2018). That article is a review, not a new controlled trial, and should be read as a map to earlier reports rather than as standalone clinical evidence.

Identity still has to be documented for the lot on the bench. GHK and GHK-Cu are not the same specification. See What Is GHK-Cu? Identity, Copper Complex, and Laboratory Documentation and Copper-Binding Peptides in Laboratory Models. Catalog specifications, where published, are on the GHK-Cu product page and in the product directory. Related copper-binding names in a catalog should be specified as their own line items; they are not substitutes for GHK-Cu.

RU58841 and androgen-receptor research

RU58841 (also written RU 58841) is a non-steroidal antiandrogen used in laboratory models of androgen-receptor signaling and hair-follicle biology. It is a small molecule, not a peptide, and it should be documented with methods suited to that chemical class.

Battmann and colleagues characterized RU 58841 as a topical non-steroidal antiandrogen with high affinity for hamster androgen receptors, and they reported dose-dependent regression of hamster flank-organ area after topical application, with limited systemic antiandrogenic activity in those animal models (Battmann et al., 1994).

In a controlled study of balding human scalp grafts maintained on testosterone-conditioned nude mice, De Brouwer and colleagues reported higher linear hair growth rates and a larger share of follicles initiating a second cycle in the RU58841-treated group than in the vehicle group (De Brouwer et al., 1997). That is a finding in a graft model, not a completed clinical trial.

Pan and colleagues reported that RU58841 competitively suppressed dihydrotestosterone activation of wild-type androgen receptor in a prostate PC3 reporter system, and that topical application increased hair density, thickness, and length in a stumptailed-macaque model of androgenetic alopecia, without detected systemic effects in that study (Pan et al., 1998). In related macaque dermal-papilla coculture work, Obana and colleagues reported that RU 58841 antagonized testosterone-induced inhibition of outer-root-sheath cell proliferation (Obana et al., 1997).

A related identity note is at What Is RU58841? A Research Compound Overview. Findings in one model should not be transferred automatically to another, and none of these papers is a use instruction.

PP405 and mitochondrial-metabolism models

The original overview names PP405 in connection with mitochondrial-metabolism models used in hair-follicle research. A 2021 medicinal-chemistry paper reported that novel inhibitors of the mitochondrial pyruvate carrier (MPC) increased lactate production in cell assays and, after topical application, promoted hair growth on shaved mice (Liu et al., 2021). That paper describes a chemical series, including analogues of UK-5099; it does not, in the verified record used for this draft, identify a disclosed structure under the catalog or code name “PP405.”

Citation flag. A peer-reviewed paper that both uses the name PP405 and fully identifies the same chemical entity was not verified here. Company announcements, trial-registry postings, and secondary reviews that quote clinical percentages are therefore not cited as evidence. Until such a paper can be checked, PP405 should be treated as a named research code that requires a confirmed chemical identity on the quotation, the label, and the analytical report.

A related catalog-style overview is at What Is PP405? A Research Compound Overview.

Documentation for mixed-class hair-follicle work

Because these materials are not one chemical class, a procurement file should keep separate rows for a copper peptide, a non-steroidal antiandrogen, and any mitochondrial-metabolism compound. Ask for the report that belongs to each offered lot. What Is a Peptide COA? and How to Read a Peptide COA cover the report side of that file; lot traceability covers the wider record chain. Reference-sample reports are in the COA Library; confirm current-lot applicability before ordering.

Selected published literature

  1. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343-346. doi:10.1016/0014-5793(88)80509-X. PubMed 3169264.
  2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987. doi:10.3390/ijms19071987. PubMed 29986520. Review article.
  3. Battmann T, Bonfils A, Branche C, Humbert J, Goubet F, Teutsch G, Philibert D. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. The Journal of Steroid Biochemistry and Molecular Biology. 1994;48(1):55-60. doi:10.1016/0960-0760(94)90250-X. PubMed 8136306.
  4. De Brouwer B, Tételin C, Leroy T, Bonfils A, Van Neste D. A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice. British Journal of Dermatology. 1997;137(5):699-702. doi:10.1111/j.1365-2133.1997.tb01104.x. PubMed 9415227.
  5. Pan HJ, Wilding G, Uno H, Inui S, Goldsmith L, Messing E, Chang C. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques. Endocrine. 1998;9(1):39-43. doi:10.1385/endo:9:1:39. PubMed 9798729.
  6. Obana N, Chang C, Uno H. Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque. Endocrinology. 1997;138(1):356-361. doi:10.1210/endo.138.1.4890. PubMed 8977424.
  7. Liu X, Flores AA, Situ L, Gu W, Ding H, Christofk HR, Lowry WE, Jung ME. Development of novel mitochondrial pyruvate carrier inhibitors to treat hair loss. Journal of Medicinal Chemistry. 2021;64(4):2046-2063. doi:10.1021/acs.jmedchem.0c01570. PubMed 33534563. Cited for the MPC-inhibitor class in laboratory models; not verified here as a PP405-named structure disclosure.

Sourcing notes for qualified buyers

Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.

Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.

Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.

My inquiry listNo products added yet0